This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 May;2(1):51-2.

doi: 10.1016/S1533-0028(11)70502-3.

Inhibiting 5-fluorouracil breakdown: a broken down approach to 5-fluorouracil modulation

Richard L Schilsky¹

Affiliations

PMID: 12453336
DOI: 10.1016/S1533-0028(11)70502-3

Comment

Inhibiting 5-fluorouracil breakdown: a broken down approach to 5-fluorouracil modulation

Richard L Schilsky. Clin Colorectal Cancer. 2002 May.

. 2002 May;2(1):51-2.

doi: 10.1016/S1533-0028(11)70502-3.

Author

Richard L Schilsky¹

Affiliation

¹ Biological Sciences Division, University of Chicago, IL, USA.

PMID: 12453336
DOI: 10.1016/S1533-0028(11)70502-3

No abstract available

PubMed Disclaimer

Comment on

Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer.
Marsh JC, Catalano P, Huang J, Graham DL, Cornfeld MJ, O'Dwyer PJ, Benson AB 3rd. Marsh JC, et al. Clin Colorectal Cancer. 2002 May;2(1):43-50. doi: 10.3816/CCC.2002.n.010. Clin Colorectal Cancer. 2002. PMID: 12453335 Clinical Trial.

Similar articles

Can eniluracil improve 5-fluorouracil therapy?
Diasio RB. Diasio RB. Clin Colorectal Cancer. 2002 May;2(1):53. doi: 10.1016/S1533-0028(11)70503-5. Clin Colorectal Cancer. 2002. PMID: 12453337 No abstract available.
[Fluorinated pyrimidines in oral treatment of advanced colorectal cancer].
Todnem K, Harboe K, Zotova L, Lind A, Ogreid D. Todnem K, et al. Tidsskr Nor Laegeforen. 2000 Sep 30;120(23):2781-5. Tidsskr Nor Laegeforen. 2000. PMID: 11107924 Review. Norwegian.
Clinical development of eniluracil: current status.
Hohneker JA. Hohneker JA. Oncology (Williston Park). 1998 Oct;12(10 Suppl 7):52-6. Oncology (Williston Park). 1998. PMID: 9830627 Review.
Oral eniluracil/5-FU for advanced colon and breast carcinomas.
Benson AB 3rd. Benson AB 3rd. Oncology (Williston Park). 2001 Jan;15(1 Suppl 2):57-63; discussion 64. Oncology (Williston Park). 2001. PMID: 11219979 Review.
Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil.
van Kuilenburg AB. van Kuilenburg AB. Eur J Cancer. 2004 May;40(7):939-50. doi: 10.1016/j.ejca.2003.12.004. Eur J Cancer. 2004. PMID: 15093568 Review.

See all similar articles

Cited by

Oral versus intravenous fluoropyrimidines for colorectal cancer.
Chionh F, Lau D, Yeung Y, Price T, Tebbutt N. Chionh F, et al. Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD008398. doi: 10.1002/14651858.CD008398.pub2. Cochrane Database Syst Rev. 2017. PMID: 28752564 Free PMC article.
Oral Tegafur-Uracil Combination plus Leucovorin versus Other Fluoropyrimidine Agents in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Kataria SP, Nagar M, Verma S, Purohit V. Kataria SP, et al. South Asian J Cancer. 2022 Feb 2;11(1):84-94. doi: 10.1055/s-0041-1735650. eCollection 2022 Jan. South Asian J Cancer. 2022. PMID: 35833043 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information